Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2025-12-24 @ 9:11 PM
NCT ID:
NCT00339404
Eligibility Criteria:
* INCLUSION CRITERIA:
Inclusion into this study was restricted to families containing at least three CMM cases with DNA available for genotyping, and CDKN2A and CDK4 involvement and had been excluded.
All families must be mutation negative for both CDKN2A and CDK4.
This study will also include families with at least one case of ocular and two cases of other cutaneous melanomas, or at least 2 ocular melanomas (except where they occur in parent and child).
EXCLUSION CRITERIA:
Any family showing evidence of haplotype sharing in the 9p21-p22 region, where CDKN2A is located, was also excluded.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00339404
Study Brief:
Protocol Section:
NCT00339404